ALLMedicine™ Bacterial Sepsis Center
Research & Reviews 385 results
https://doi.org/10.1016/j.ijbiomac.2023.124025
International Journal of Biological Macromolecules; Ansari MSH, Kumar N et. al.
Mar 16th, 2023 - The mycobacteriophages encode unique proteins that are potent to be therapeutic agents. We screened several clones with mycobactericidal properties from a genomic library of mycobacteriophages. Here we report the properties of one such clone codin...
https://emedicine.medscape.com/article/1204298-overview
Mar 14th, 2023 - Background Fungi are eukaryotic organisms that are ubiquitous in nature. The following 3 classes of fungi are important ocular pathogens: molds, yeasts, and diphasic fungi. Molds, also known as filamentous fungi, are multicellular organisms that f...
https://emedicine.medscape.com/article/1204298-print
Mar 14th, 2023 - Background Fungi are eukaryotic organisms that are ubiquitous in nature. The following 3 classes of fungi are important ocular pathogens: molds, yeasts, and diphasic fungi. Molds, also known as filamentous fungi, are multicellular organisms that f...
http://emedicine.medscape.com/article/1204298-overview
Mar 14th, 2023 - Background Fungi are eukaryotic organisms that are ubiquitous in nature. The following 3 classes of fungi are important ocular pathogens: molds, yeasts, and diphasic fungi. Molds, also known as filamentous fungi, are multicellular organisms that f...
https://doi.org/10.1182/blood.2022018017
Blood Stanworth SJ, Mumford AD
Feb 15th, 2023 - Neonatal thrombocytopenia defined as the presence of a circulating platelet count <150x109/L is a common abnormality in babies admitted to Neonatal Intensive Care Units. Thrombocytopenia that is typically mild and self-limiting often accompanies n...
Drugs 13 results see all →
Clinicaltrials.gov 29 results
https://clinicaltrials.gov/ct2/show/NCT02780583
Feb 13th, 2023 - Macrophage activation syndrome (MAS) is a disorder whereby the immune system generates very high levels of substances (cytokines) that promote inflammation to the extent dysfunction occurs in multiple organ systems which if unchecked, is frequentl...
https://clinicaltrials.gov/ct2/show/NCT05612893
Nov 10th, 2022 - Aging could influence host immune response. Elderly people are more likely to progress to severe pneumonia than young people. Nasal mucosa is the initial infection site of influenza infection. Single cell sequencing of nasal mucosal cell that may ...
https://clinicaltrials.gov/ct2/show/NCT04517695
Oct 12th, 2022 - Acute respiratory failure related to infection by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is the main reason for ICU admission in in the majority of patients admitted to the ICU in this viral syndrome, and it presents a s...
https://clinicaltrials.gov/ct2/show/NCT05490498
Aug 5th, 2022 - Breast milk contains many microorganisms including bacteria that are beneficial to health (probiotics), but also bacteria that are generally considered pathogenic. Several studies have described an increased risk of infections due to pathogenic ge...
https://clinicaltrials.gov/ct2/show/NCT04896567
Aug 3rd, 2022 - Endothelial dysfunction is central to the pathophysiology of vascular ischemia, bacterial sepsis, toxin-induced thrombotic microangiopathy, and antibody-mediated kidney transplant rejection and often manifest with renal failure. With each of these...
News 39 results
https://www.medscape.com/viewarticle/979342
Aug 17th, 2022 - The US Food and Drug Administration today approved a citrate-free, high-concentration formulation of adalimumab-bwwd (Hadlima), the manufacturer, Samsung Bioepis, and its commercialization partner Organon said in an announcement. Hadlima is a bios...
https://www.medpagetoday.com/gastroenterology/pancreaticdiseases/99858
Jul 22nd, 2022 - Using procalcitonin-based algorithms reduced the use of antibiotics in patients with acute pancreatitis, with no increased risk of infection or harm, a randomized trial in the U.K. showed. In an intention-to-treat analysis involving 260 patients, ...
https://www.onclive.com/view/momelotinib-sustains-long-term-survival-in-patients-with-myelofibrosis
Dec 20th, 2020 - Momelotinib improved overall survival (OS) and sustained efficacy outcomes in patients with intermediate- or high-risk myelofibrosis, according to updated findings from the phase 3 SIMPLIFY-1 and SIMPLIFY-2 trials.1,2 Lead author Srdan Verstovsek...
https://www.onclive.com/view/fda-grants-momelotinib-fast-track-designation-in-myelofibrosis
Dec 4th, 2020 - Barbara Klencke, MD The FDA has granted momelotinib a fast track designation for use as a treatment of patients with intermediate- or high-risk myelofibrosis who previously received a JAK inhibitor.1 Sierra Oncology, the developer of the JAK1/JA...
https://www.medscape.com/viewarticle/939038
Oct 16th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection that can be bacterial, fungal, protozoal, or viral in origin, ...